HER2 amplification leading to HER2 protein overexpression is associated with downstream activated signaling pathways, leading to dysregulated cell proliferation, including breast cancer, esophagogastric cancer, and CRC4. The gene discussed is ERBB2; the disease is breast carcinoma.